NL6616277A - - Google Patents
Info
- Publication number
- NL6616277A NL6616277A NL6616277A NL6616277A NL6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A NL 6616277 A NL6616277 A NL 6616277A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
- C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1598865A CH474486A (de) | 1965-11-19 | 1965-11-19 | Verfahren zur Herstellung neuer Diphenylharnstoffe |
CH1409266 | 1966-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL6616277A true NL6616277A (xx) | 1967-05-22 |
Family
ID=25713607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL6616277A NL6616277A (xx) | 1965-11-19 | 1966-11-18 |
Country Status (11)
Country | Link |
---|---|
US (2) | US3560566A (xx) |
AT (1) | AT269166B (xx) |
BE (1) | BE689902A (xx) |
BR (1) | BR6684680D0 (xx) |
CH (1) | CH474486A (xx) |
DE (1) | DE1568349A1 (xx) |
DK (1) | DK118457B (xx) |
FR (3) | FR1504097A (xx) |
GB (1) | GB1142066A (xx) |
NL (1) | NL6616277A (xx) |
SE (1) | SE323360B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1311432A (en) * | 1971-01-07 | 1973-03-28 | Ici Ltd | Guanidine derivatives their preparation and antiviral compositions containing them |
DE3360148D1 (en) * | 1982-02-10 | 1985-06-05 | Beecham Group Plc | Guanidine derivatives |
US5238941A (en) * | 1988-03-25 | 1993-08-24 | Ciba-Geigy Corporation | Arylhydrazones and pharmaceutical compositions thereof |
US4971986A (en) * | 1988-03-25 | 1990-11-20 | Ciba-Geigy Corporation | Arylhydrazones useful as SAMDC inhibitors |
US6008255A (en) * | 1994-01-21 | 1999-12-28 | The Picower Institute For Medical Research | Guanylhydrazones and their use to treat inflammatory conditions |
US5599984A (en) * | 1994-01-21 | 1997-02-04 | The Picower Institute For Medical Research | Guanylhydrazones and their use to treat inflammatory conditions |
WO2002000613A2 (en) * | 2000-06-27 | 2002-01-03 | Axxima Pharmaceuticals Ag | Inhibitors of hepatitis b virus infection |
US20050282909A1 (en) * | 2003-11-14 | 2005-12-22 | Diks Sander H | Guanylhydrazones in methods of treatment or diagnosis as modulators of signal transduction |
DK1778265T3 (da) * | 2004-08-17 | 2013-06-24 | Ferring Bv | Guanylhydrazoneforbindelser, sammensætninger, fremgangsmåder og anvendelse |
EP1912635B1 (en) * | 2005-07-29 | 2014-03-05 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Use of chk2 kinase inhibitors for cancer treatment |
EP2155675B1 (en) | 2007-06-12 | 2014-02-19 | Provid Pharmaceuticals, Inc. | Kinase inhibitors, compositions thereof, and methods of use therewith |
US20160152560A1 (en) * | 2013-05-28 | 2016-06-02 | The Regents Of The University Of California | Compounds for the treatment of hypertension and hypertensive end stage renal disease |
-
1965
- 1965-11-19 CH CH1598865A patent/CH474486A/de not_active IP Right Cessation
-
1966
- 1966-11-11 DE DE19661568349 patent/DE1568349A1/de active Pending
- 1966-11-14 GB GB50898/66A patent/GB1142066A/en not_active Expired
- 1966-11-15 US US594386A patent/US3560566A/en not_active Expired - Lifetime
- 1966-11-17 FR FR83919A patent/FR1504097A/fr not_active Expired
- 1966-11-18 NL NL6616277A patent/NL6616277A/xx unknown
- 1966-11-18 BE BE689902D patent/BE689902A/xx unknown
- 1966-11-18 SE SE15811/66A patent/SE323360B/xx unknown
- 1966-11-18 DK DK598166AA patent/DK118457B/da unknown
- 1966-11-18 BR BR184680/66A patent/BR6684680D0/pt unknown
- 1966-11-18 AT AT119368A patent/AT269166B/de active
-
1967
- 1967-02-14 FR FR94793A patent/FR6139M/fr not_active Expired
- 1967-02-14 FR FR94794A patent/FR6153M/fr not_active Expired
- 1967-07-11 US US652409A patent/US3560557A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
BR6684680D0 (pt) | 1973-12-18 |
DK118457B (da) | 1970-08-24 |
US3560557A (en) | 1971-02-02 |
CH474486A (de) | 1969-06-30 |
AT269166B (de) | 1969-03-10 |
FR6139M (xx) | 1968-06-24 |
US3560566A (en) | 1971-02-02 |
FR1504097A (fr) | 1967-12-01 |
DE1568349A1 (de) | 1970-02-12 |
GB1142066A (en) | 1969-02-05 |
SE323360B (xx) | 1970-05-04 |
BE689902A (xx) | 1967-05-18 |
FR6153M (xx) | 1968-07-01 |